1. Home
  2. JRSH vs XLO Comparison

JRSH vs XLO Comparison

Compare JRSH & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JRSH
  • XLO
  • Stock Information
  • Founded
  • JRSH 2016
  • XLO 2016
  • Country
  • JRSH United States
  • XLO United States
  • Employees
  • JRSH N/A
  • XLO N/A
  • Industry
  • JRSH Apparel
  • XLO Biotechnology: Pharmaceutical Preparations
  • Sector
  • JRSH Consumer Discretionary
  • XLO Health Care
  • Exchange
  • JRSH Nasdaq
  • XLO Nasdaq
  • Market Cap
  • JRSH 44.5M
  • XLO 37.9M
  • IPO Year
  • JRSH 2018
  • XLO 2021
  • Fundamental
  • Price
  • JRSH $3.06
  • XLO $0.68
  • Analyst Decision
  • JRSH
  • XLO Buy
  • Analyst Count
  • JRSH 0
  • XLO 1
  • Target Price
  • JRSH N/A
  • XLO $4.00
  • AVG Volume (30 Days)
  • JRSH 12.2K
  • XLO 402.1K
  • Earning Date
  • JRSH 02-11-2025
  • XLO 05-13-2025
  • Dividend Yield
  • JRSH 6.21%
  • XLO N/A
  • EPS Growth
  • JRSH N/A
  • XLO N/A
  • EPS
  • JRSH N/A
  • XLO N/A
  • Revenue
  • JRSH $138,135,034.00
  • XLO $6,344,000.00
  • Revenue This Year
  • JRSH $29.89
  • XLO $725.74
  • Revenue Next Year
  • JRSH $8.30
  • XLO N/A
  • P/E Ratio
  • JRSH N/A
  • XLO N/A
  • Revenue Growth
  • JRSH 15.70
  • XLO N/A
  • 52 Week Low
  • JRSH $2.68
  • XLO $0.63
  • 52 Week High
  • JRSH $4.17
  • XLO $1.70
  • Technical
  • Relative Strength Index (RSI)
  • JRSH 18.18
  • XLO 38.05
  • Support Level
  • JRSH $3.33
  • XLO $0.69
  • Resistance Level
  • JRSH $3.64
  • XLO $0.75
  • Average True Range (ATR)
  • JRSH 0.11
  • XLO 0.05
  • MACD
  • JRSH -0.04
  • XLO -0.00
  • Stochastic Oscillator
  • JRSH 0.00
  • XLO 1.84

About JRSH Jerash Holdings (US) Inc.

Jerash Holdings (US) Inc along with its subsidiaries is a manufacturer and exporter of customized, ready-made sport and outerwear from knitted fabric from its production facilities in Jordan. The company manufactures for retailers namely Walmart, Costco, Sears, Hanes, Columbia, Land's End, VF Corporation, and Philip-Van Heusen which owns brands such as The North Face, Nautica, Timberland, Wrangler, Lee, Jansport, Calvin Klein, Tommy Hilfiger, IZOD, Speedo etc. It derives its revenue from the manufacturing and sales of outerwear in the United States. The company's product offering consists of jackets, polo shirts, crew neck shirts, pants, and shorts made from knitted fabric. Geographically, the company generates maximum revenue from the United States.

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies (including bispecifics) and immune cell engagers (including tumor-activated cell engagers and tumor-activated effector-enhanced cell engagers).

Share on Social Networks: